Models of Herpes Simplex Virus Latency

• Published in: Viruses 2024-05, Vol.16 (5), p.747
• Main Authors: Canova, Paige N, Charron, Audra J, Leib, David A
• Format: Article
• Language: English
• Subjects: Analysis; Animals; Autophagy; Disease; Disease Models, Animal; Epigenetics; Gene expression; Genomes; Herpes simplex; Herpes Simplex - virology; Herpes viruses; Herpesvirus 1, Human - genetics; Herpesvirus 1, Human - physiology; HSV; Humans; Immune response; in vivo and in vitro models; Infection; Infections; Kinases; Latency; MicroRNAs; Multiple sclerosis; Neurons; Neurophysiology; organoids; Protein synthesis; Proteins; reactivation; RNA polymerase; Simplexvirus - physiology; Virus Latency
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v16050747

Our current understanding of HSV latency is based on a variety of clinical observations, and in vivo, ex vivo, and in vitro model systems, each with unique advantages and drawbacks. The criteria for authentically modeling HSV latency include the ability to easily manipulate host genetics and biological pathways, as well as mimicking the immune response and viral pathogenesis in human infections. Although realistically modeling HSV latency is necessary when choosing a model, the cost, time requirement, ethical constraints, and reagent availability are also equally important. Presently, there remains a pressing need for in vivo models that more closely recapitulate human HSV infection. While the current in vivo, ex vivo, and in vitro models used to study HSV latency have limitations, they provide further insights that add to our understanding of latency. In vivo models have shed light on natural infection routes and the interplay between the host immune response and the virus during latency, while in vitro models have been invaluable in elucidating molecular pathways involved in latency. Below, we review the relative advantages and disadvantages of current HSV models and highlight insights gained through each.